Combination Therapy with Chinese Medicine and ACEI/ARB for the Management of Diabetic Nephropathy: The Promise in Research Fragments

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|13|4|526-539

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.13, Iss.4, 2015-01, pp. : 526-539

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Update in the Management of Diabetic Nephropathy

By  

Current Diabetes Reviews, Vol. 9, Iss. 1, 2013-01 ,pp. : 62-77

Bentham Science Publishers

Access to resources Recommend Favorite

Telmisartan in the Management of Diabetic Nephropathy: A Contemporary View

By  

Current Diabetes Reviews, Vol. 8, Iss. 3, 2012-05 ,pp. : 183-190

Bentham Science Publishers

Access to resources Recommend Favorite

Innovative Strategy in Treating Angina Pectoris with Chinese Patent Medicines by Promoting Blood Circulation and Removing Blood Stasis: Experience from Combination Therapy in Chinese Medicine

By  

Current Vascular Pharmacology, Vol. 13, Iss. 4, 2015-01 ,pp. : 540-553

Bentham Science Publishers

Access to resources Recommend Favorite

Diverse combination therapies of Chinese Medicine in treating Hypertension

By  

Current Vascular Pharmacology, Vol. 13, Iss. 4, 2015-01 ,pp. : 504-519

Bentham Science Publishers

Access to resources Recommend Favorite

A Review of Oxidative Stress Related Genes and New Antioxidant Therapy in Diabetic Nephropathy

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 9, Iss. 4, 2011-10 ,pp. : 253-261

Bentham Science Publishers

Access to resources Recommend Favorite